MIMS (Malaysia) drug information results matching Tarivid Otic
User Information
NEWS | CME 
 Non-HDL Cholesterol: When and how to Treat   7th International Symposium on Respiratory Diseases (ISRD)   The JUPITER trial: Do the results apply to Asians?   Coronary CT predicts future cardiac events   Gefitinib improves progression-free survival in NSCLC with EGFR mutations   Women's heart attacks differ from men's   Researchers in Asia point to better sepsis treatments   Recommendations for the Management of Neuropathic Pain Associated With Peripheral Nerve Entrapment   Ethnicity is a strong indicator of cardiovascular risk   Asian lung cancer vaccine trial resumes after temporary hold   Conflicting Recommendations for Lipid Screening and Management in Children: The Need for Consensus   Chinese women largely unaware of heart disease and stroke risk   Community-based lifestyle intervention beneficial in Chinese diabetes, hypertension patients   Type 1 Diabetes Mellitus in Children and Adolescents   Linagliptin lowers blood sugar in type 2 diabetics   
MIMS Info PubMed
Results 1-1 of 1 for Tarivid Otic (0 seconds)
Other(s): China  HK  India  Indonesia  Malaysia  Phil  S'pore  Taiwan  Thai  US  Vietnam  ALL  
Display: Brief  Full      Search in: Drug Only  All  
Tarivid Otic ear drops® [ Daiichi Sankyo ]  [ First Pharmaceutical ] - ofloxacin
Indication: Infections caused by staph, strep, proteus, Pseudomonas aeruginosa, Haemophilus influenzae. Chronic suppurative otitis media, acute otitis media w/ tympanostomy tube, otitis externa.
MIMS Class: Ear Anti-Infectives & Antiseptics 
Image  Interaction  Patient MedInfo  Search PubMed  

 
  
 
China MIMS Online Home Page Hong Kong MIMS Online Home Page India MIMS Online Home Page Indonesia MIMS Online Home Page Malaysia MIMS Online Home Page Philippines MIMS Online Home Page Singapore MIMS Online Home Page Taiwan MIMS Online Home Page Thailand MIMS Online Home Page Vietnam MIMS Online Home Page